JP2011528007A5 - - Google Patents

Download PDF

Info

Publication number
JP2011528007A5
JP2011528007A5 JP2011517863A JP2011517863A JP2011528007A5 JP 2011528007 A5 JP2011528007 A5 JP 2011528007A5 JP 2011517863 A JP2011517863 A JP 2011517863A JP 2011517863 A JP2011517863 A JP 2011517863A JP 2011528007 A5 JP2011528007 A5 JP 2011528007A5
Authority
JP
Japan
Prior art keywords
dione
trifluoromethyl
triazine
group
alkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2011517863A
Other languages
English (en)
Japanese (ja)
Other versions
JP5599788B2 (ja
JP2011528007A (ja
Filing date
Publication date
Priority claimed from FR0854794A external-priority patent/FR2933979B1/fr
Application filed filed Critical
Publication of JP2011528007A publication Critical patent/JP2011528007A/ja
Publication of JP2011528007A5 publication Critical patent/JP2011528007A5/ja
Application granted granted Critical
Publication of JP5599788B2 publication Critical patent/JP5599788B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2011517863A 2008-07-15 2009-07-07 トリアジンおよびウラシルの誘導体、それらの調製、およびヒト治療薬におけるそれらの応用 Expired - Fee Related JP5599788B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR0854794A FR2933979B1 (fr) 2008-07-15 2008-07-15 Derives de triazines et uraciles, leur preparation et leur application en therapeutique humaine
FR0854794 2008-07-15
PCT/EP2009/058609 WO2010006962A1 (en) 2008-07-15 2009-07-07 Derivatives of triazines and uracils, their preparation and their application in human therapeutics

Publications (3)

Publication Number Publication Date
JP2011528007A JP2011528007A (ja) 2011-11-10
JP2011528007A5 true JP2011528007A5 (https=) 2012-08-30
JP5599788B2 JP5599788B2 (ja) 2014-10-01

Family

ID=40394394

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2011517863A Expired - Fee Related JP5599788B2 (ja) 2008-07-15 2009-07-07 トリアジンおよびウラシルの誘導体、それらの調製、およびヒト治療薬におけるそれらの応用

Country Status (7)

Country Link
US (1) US8618287B2 (https=)
EP (1) EP2328886B1 (https=)
JP (1) JP5599788B2 (https=)
AR (1) AR072510A1 (https=)
FR (1) FR2933979B1 (https=)
TW (1) TW201006815A (https=)
WO (1) WO2010006962A1 (https=)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103664873B (zh) 2009-12-30 2016-06-15 深圳信立泰药业股份有限公司 作为二肽基肽酶iv(dpp-iv)抑制剂的3-(3-氨基哌啶-1-基)-5-氧代-1,2,4-三嗪衍生物
FR2958935B1 (fr) 2010-04-19 2012-06-22 Pf Medicament Derives d'heterocycles azotes, leur preparation et leur application en therapeutique humaine
CN104803971B (zh) * 2014-01-24 2021-11-30 深圳信立泰药业股份有限公司 化合物A单苯甲酸盐的晶型α及其制备方法和含有该晶型的药物组合物
CN105017213B (zh) * 2014-04-30 2017-11-14 成都苑东生物制药股份有限公司 尿嘧啶衍生物
EP3189046B1 (en) 2014-09-05 2020-08-26 Genentech, Inc. Therapeutic compounds and uses thereof
US11970486B2 (en) 2016-10-24 2024-04-30 Janssen Pharmaceutica Nv Compounds and uses thereof
EA201991650A1 (ru) 2017-01-06 2020-01-20 Юманити Терапьютикс, Инк. Способы лечения неврологических расстройств
CA3083000A1 (en) 2017-10-24 2019-05-02 Yumanity Therapeutics, Inc. Compounds and uses thereof
BR112020019191A2 (pt) 2018-03-23 2021-01-05 Yumanity Therapeutics, Inc. Compostos e seus usos
TWI840423B (zh) * 2018-10-12 2024-05-01 美商拓臻股份有限公司 甲狀腺素受體β促效劑化合物
CN111320609A (zh) 2018-12-13 2020-06-23 拓臻股份有限公司 一种THRβ受体激动剂化合物及其制备方法和用途
MX2021008903A (es) 2019-01-24 2021-11-04 Yumanity Therapeutics Inc Compuestos y usos de los mismos.
AU2020336272A1 (en) 2019-08-23 2022-04-14 Terns Pharmaceuticals, Inc. Thyroid hormone receptor beta agonist compounds
CN114375193B (zh) 2019-09-12 2024-05-14 拓臻制药公司 甲状腺激素受体β激动剂化合物
EA202192047A1 (ru) 2019-11-13 2021-12-08 Юманити Терапьютикс, Инк. Соединения и их применение
EP4083024A4 (en) 2019-11-26 2023-11-01 KPC Pharmaceuticals, Inc. 1,2,4-TRIAZINE-3,5-DIONE COMPOUND, METHOD FOR PRODUCTION THEREOF AND USE THEREOF
WO2024102455A1 (en) * 2022-11-09 2024-05-16 Emory University Non-covalent inhibitors of coronavirus main protease
US20240398794A1 (en) 2023-04-07 2024-12-05 Terns Pharmaceuticals, Inc. COMBINATIONS OF GLP-1R AND THRß AGONISTS AND METHODS OF USE THEREOF

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5973573A (ja) * 1982-09-09 1984-04-25 ワ−ナ−−ランバ−ト・コンパニ− ジアミノピリミジン化合物
CA2501611A1 (en) * 2002-10-11 2004-04-22 Astrazeneca Ab 1,4-disubstituted piperidine derivatives and their use as 11-betahsd1 inhibitors
FR2866339B1 (fr) * 2004-02-18 2006-05-05 Pf Medicament Derives de 1,2,4-triazines, leur preparation et leur application en therapeutique humaine
TW200609219A (en) * 2004-06-17 2006-03-16 Neurogen Corp Aryl-substituted piperazine derivatives
EP1966183A4 (en) * 2005-12-20 2010-12-29 Merck Frosst Canada Ltd HETEROAROMATIC COMPOUNDS AS INHIBITORS OF STEAROYL-COENZYME A-DELTA-9-DESATURASE

Similar Documents

Publication Publication Date Title
JP2011528007A5 (https=)
TW502025B (en) Pyridazine derivatives having inhibitory activity against interleukin-1β production and pharmaceutical composition containing the same
KR101553418B1 (ko) 피리다지논 유도체
CN100502863C (zh) 2,4,5-三取代噻唑衍生物和它们的抗炎活性
CN1152867C (zh) 作为药物的喹唑啉衍生物
EP2178870B1 (en) Indole and indazole compounds as an inhibitor of cellular necrosis
JP2008513514A5 (https=)
AU2018282336A1 (en) Trk-inhibiting compound
JP2007500715A5 (https=)
DE102008062826A1 (de) Pyridazinonderivate
US6469018B1 (en) Compounds
CN112638876B (zh) 用于治疗rna病毒感染的苯基/吡啶基-n-苯基/吡啶基衍生物
CZ20004339A3 (cs) Nové 2-alkylem substituované imidazolové sloučeniny
EP1448556A1 (en) Heteroaryl amines as glycogen synthase kinase 3beta inhibitors (gsk3 inhibitors)
JP2972377B2 (ja) カテコール誘導体、その薬学的に許容しうる塩およびエステルならびにそれらを含有する医薬組成物
AU2002363176A1 (en) Heteroaryl amines as glycogen synthase kinase 3Beta inhibitors (GSK3 inhibitors)
WO2010017870A1 (de) Bicyclische triazolderivate zur behandlung von tumoren
EP1351691A1 (en) Substituted 2-aryl-4-arylaminopyrimidines and analogs as activators of caspases and inducers of apoptosis and the use thereof
JP2012525431A5 (https=)
WO2008145243A1 (de) Pyridazinonderivate
DE102008019907A1 (de) Pyridazinonderivate
JP2010516701A5 (https=)
EP2176236A1 (de) 6-thioxo-pyridazinderivate
JP2011528007A (ja) トリアジンおよびウラシルの誘導体、それらの調製、およびヒト治療薬におけるそれらの応用
JP2012529513A (ja) トリアジン誘導体類及びそれらの治療応用